Cipla USA Inc. Recalls

7 recalls found for Cipla USA Inc.. Check if any of your products are affected.

HIGHFDA DRUG

Cipla USA Recalls Cinacalcet Hydrochloride Tablets Over Impurity Risk

Cipla USA recalled 12,576 bottles of Cinacalcet Hydrochloride Tablets on November 14, 2025, due to a nitrosamine impurity. The impurity, N-nitroso-cinacalcet, exceeds acceptable daily intake limits. Consumers must stop using this product immediately and contact healthcare providers for guidance.

CINACALCET
CGMP Deviations:
Read more
HIGHFDA DRUG

Cipla USA Recalls Cinacalcet Hydrochloride Tablets Over Nitrosamine Hazard

Cipla USA, Inc. recalled 15,744 bottles of Cinacalcet Hydrochloride Tablets on November 14, 2025. The recall follows the discovery of a nitrosamine impurity exceeding acceptable daily intake limits. Consumers should stop using the product immediately and consult healthcare providers.

CINACALCET
CGMP Deviations:
Read more
HIGHFDA DRUG

Cipla Recalls Cinacalcet Hydrochloride Tablets Over Impurity Risk

Cipla USA, Inc. recalled 63,504 bottles of Cinacalcet Hydrochloride Tablets on November 14, 2025. The recall results from a nitrosamine impurity, N-nitroso-cinacalcet, exceeding acceptable daily intake limits. Consumers should stop using the tablets immediately and contact healthcare providers for guidance.

CINACALCET
CGMP Deviations:
Read more
HIGHFDA DRUG

Cipla USA Recalls Lanthanum Carbonate Tablets Over Stability Issues

Cipla USA recalled 1,180 boxes of Lanthanum Carbonate chewable tablets on October 24, 2025. The recall follows a failure to meet stability specifications for hardness tests. Consumers and healthcare providers must stop using the product immediately.

LANTHANUM CARBONATE
Failed stability
Read more
HIGHFDA DRUG

Cipla USA Recalls Albuterol Inhalation Aerosol for Stability Issues

Cipla USA, Inc. recalled 20,352 packs of Albuterol Sulfate inhalation aerosol on July 24, 2025. The recall follows out-of-specification results in particle size distribution during stability testing. Consumers must stop using the product immediately.

Cipla USA Inc.
Failed Stability
Read more